NUSIRT
NuSirt Sciences is a biotechnology company focused on developing products targeting metabolic diseases associated with over-nutrition such as obesity, diabetes, and inflammatory stress. The company has developed a breakthrough technology platform that combines natural compounds with various pharmaceutical agents. NuSirts first product, NS-0100, uses NuSirts platform technology to combine the natural product leucine with a very low dose of metformin for the treatment of type II diabetes. Althoug... h, metformin is the gold standard in the treatment of early-type II diabetes many patients can not tolerate the adverse gastrointestinal side effects metformin can cause in some patients. The company is currently testing varying doses of NS-0100 in Phase 2 clinical study to find the most efficacious dose of this new combination. If NuSirts clinical trials are successful NS-0100 may offer patients a viable alternative to metformin. NuSirt has filed eleven patent applications (two of which have been issued) and completed four clinical and numerous pre-clinical studies based on the patented technologies.
NUSIRT
Industry:
Biotechnology Clinical Trials Diabetes
Founded:
2007-01-01
Address:
Nashville, Tennessee, United States
Country:
United States
Website Url:
http://www.nusirt.com
Total Employee:
1+
Status:
Active
Contact:
(615) 810-8191
Email Addresses:
[email protected]
Total Funding:
15.98 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt WordPress Wordpress Plugins Nginx Euro
Similar Organizations
Lytica Therapeutics
Lytica Therapeutics, Inc. is a biotechnology company focused on developing novel peptide therapeutics.
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Tennessee Community Ventures
Tennessee Community Ventures investment in Series C - Nusirt
Hatteras Venture Partners
Hatteras Venture Partners investment in Series C - Nusirt
Mountain Group Capital
Mountain Group Capital investment in Series C - Nusirt
TriStar Health Partners
TriStar Health Partners investment in Series C - Nusirt
Mountain Group Capital
Mountain Group Capital investment in Series B - Nusirt
Tennessee Community Ventures
Tennessee Community Ventures investment in Series A - Nusirt
Mountain Group Capital
Mountain Group Capital investment in Series A - Nusirt
Tennessee Community Ventures
Tennessee Community Ventures investment in Seed Round - Nusirt
Tennessee Community Ventures
Tennessee Community Ventures investment in Seed Round - Nusirt
Mountain Group Capital
Mountain Group Capital investment in Seed Round - Nusirt
Official Site Inspections
http://www.nusirt.com
- Host name: 189.28.212.35.bc.googleusercontent.com
- IP address: 35.212.28.189
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Nusirt"
Nusirt - Crunchbase Company Profile & Funding
NuSirt Sciences is a biotechnology company focused on developing products targeting metabolic diseases associated with over-nutrition such as obesity, diabetes, and inflammatory stress. …See details»
NuSirt Sciences Inc - LinkedIn
NuSirt Sciences Inc | 325 followers on LinkedIn. NuSirt BioPharma is a privately held biopharmaceutical company headquartered in Nashville TN with research labs in Knoxville, TN.See details»
About Us - NuSirt Health
NuSirt originally founded by drug developers who wanted to apply their expertise to dietary supplements. Current team consists of: Alexander Fleming, MD, NuSirt CEO, is Founder and …See details»
NuSirt Health - Natural Supplement Business
LEUSIX™ is a patented dietary supplement combining leucine and Vitamin B6 in optimized proprietary proportions, with human clinical data supporting weight management and …See details»
NuSirt Company Profile - Office Locations, Competitors, Revenue …
NuSirt Sciences is a company discovering a technology platform enabling the use of natural compounds to create synergy with known pharmaceuticals. It is used to prevent and treat …See details»
NuSirt Sciences, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for NuSirt Sciences, Inc. of Nashville, TN. Get the latest business insights from Dun & Bradstreet.See details»
NuSirt Sciences Inc - Company Profile and News - Bloomberg …
Company profile page for NuSirt Sciences Inc including stock price, company news, executives, board members, and contact informationSee details»
Nusirt - Site is undergoing maintenance
NuSirt is a pharmaceutical company that develops natural compounds to treat chronic diseases.See details»
NuSirt Biopharma - Products, Competitors, Financials, Employees ...
NuSirt Biopharma is a biopharmaceutical company focused on the development of novel drugs for the treatment of diabetes and other metabolic disorders. Use the CB Insights Platform to …See details»
Nusirt - Crunchbase
NuSirt Sciences is a biotechnology company focused on developing products.See details»
NuSirt BioPharma - PitchBook
Developer of novel drugs designed for the treatment of diabetes and other metabolic disorders.See details»
NuSirt Biopharma - VentureRadar
Website: http://nusirt.com. NuSirt Sciences, Inc. has discovered a breakthrough technology platform with the goal of enabling the use of natural compounds to create synergy with known …See details»
Clinical Trial Results Show Synergy between NuSirt Technology …
NuSirt Biopharma, headquartered in Nashville, TN, is dedicated to improving the lives of people living with chronic metabolic diseases. The company has a unique technology platform that …See details»
Nusirt - Contacts, Employees, Board Members, Advisors & Alumni
Nusirt has 3 current employee profiles, including Founder and Chief Scientific Officer Michael Zemel. Nusirt has 1 board member or advisor, William Guttman.See details»
NuSirt Biopharma Receives FDA Fast Track Designation
Dec 10, 2015 · NASHVILLE, Tenn.-- ( BUSINESS WIRE )-- NuSirt Biopharma today announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for its …See details»
Metabesity 2020: NuSirt Biopharma - YouTube
A Metabesity 2020 Emerging Company Showcase presentation on NuSirt Biopharma by Michael Zemel, PhD, Founder and CSO. NuSirt Biopharma is a privately held bio...See details»
Fast Track Granted for NAFLD and NASH Therapy - LiverSupport.com
Jan 1, 2016 · NASHVILLE, Tenn.– (BUSINESS WIRE)–NuSirt Biopharma today announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for its …See details»
Nusirt - Funding, Financials, Valuation & Investors - Crunchbase
Nusirt is funded by 4 investors. Tennessee Community Ventures and Hatteras Venture Partners are the most recent investors. Nusirt has a post-money valuation in the range of $10M to …See details»
NuSirt announces phase 2 results for leucine/metformin …
NuSirt Biopharma recently announced phase 2 results for its leucine/low-dose metformin combination (NS-0100) in type 2 diabetes showing comparable glycemic improvements and …See details»
Randomized Controlled Trial of a Leucine‐Metformin‐Sildenafil ...
AMP-activated protein kinase (AMPK) and mammalian sirtuin 1 (Sirt1) are well-known regulators of lipid and energy metabolism.See details»